Sanuwave (SNWV) Q2 Revenue Jumps 42%

Sanuwave Health (NASDAQ:SNWV), a medical technology company specializing in noninvasive wound care systems, reported its second quarter 2025 earnings on August 8, 2025. The company posted record quarterly revenue, with $10.2 million (GAAP) coming in 0.6% above analyst estimates of $10.14 million. Diluted earnings per share (EPS) was $0.01, surpassing the consensus GAAP estimate of a $(0.09) per share loss. Gross margin (GAAP) reached 78.3%, up notably compared to last year. Despite strong revenue growth, GAAP operating expenses also increased, resulting in flat GAAP operating income versus Q2 2024. Overall, the quarter showcased strong sales momentum, improved margins, and underlying profitability, but highlighted continued cost and balance sheet pressures. Source: Analyst estimates for the quarter provided by FactSet. Sanuwave Health develops and markets noninvasive medical devices that help promote wound healing. Its primary product, the UltraMIST system, uses painless ultrasound energy to accelerate healing, mainly for chronic wounds. The company also offers the PACE product platform, which applies focused shockwave technology in therapeutic settings, but revenue is almost entirely driven by the UltraMIST wound care line.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool